BioCentury
ARTICLE | Clinical News

Nulojix belatacept regulatory update

June 18, 2012 7:00 AM UTC

The Scottish Medicines Consortium recommended against the use of Nulojix belatacept from Bristol-Myers on the National Health Service (NHS) in Scotland to prevent organ rejection in adult patients rec...